Disparities in melanoma awareness

Neelam Vashi, MD, FAAD, explains the results of her cross-sectional survey investigating melanoma awareness among different racial and ethnic groups.

Related Videos
Related Content

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection: Melanoma Monday: What is it?

May 1st 2022

Immunosuppression Linked to Increased Mortality Risk in Squamous Cell Carcinoma

March 18th 2023

The Cutaneous Connection: An In-depth Dive on Sun Protective Clothing

May 1st 2022

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

Basal Cell Carcinoma Removed From President Biden’s Chest

March 3rd 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection: Melanoma Monday: What is it?

May 1st 2022

Immunosuppression Linked to Increased Mortality Risk in Squamous Cell Carcinoma

March 18th 2023

The Cutaneous Connection: An In-depth Dive on Sun Protective Clothing

May 1st 2022

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

Basal Cell Carcinoma Removed From President Biden’s Chest

March 3rd 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection: Melanoma Monday: What is it?

May 1st 2022

Immunosuppression Linked to Increased Mortality Risk in Squamous Cell Carcinoma

March 18th 2023

The Cutaneous Connection: An In-depth Dive on Sun Protective Clothing

May 1st 2022

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

Basal Cell Carcinoma Removed From President Biden’s Chest

March 3rd 2023
© 2023 MJH Life Sciences

All rights reserved.